Micronutrient optimisation is equally crucial
Board-Certified, Family Medicine TMB License #T3117 NPI: 1821613514 "Weight loss is a medical journey and every patient deserves a physician who walks it with them, not just a subscription that ships a box." Serving 265K+ residents in Lubbock and patients statewide
FAQ Wegovy, Zepbound, Saxenda, and Foundayo are approved to treat adults with a BMI of 30 or greater, or with a BMI of at least 27 and one weight-related condition, such as high blood pressure or high cholesterol
Orforglipron is the first small molecule to act as an oral GLP-1 agonist"
Common microdosing approaches The following are the common microdosing approaches: Sustained low dose: Some individuals remain indefinitely on the initial starter dose, such as 0.25 mg of semaglutide weekly, and never exceed this dose
Health economists and payers want to know the true eligible population and budget impact